474 related articles for article (PubMed ID: 27644253)
1. Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.
Peng F; Xiong L; Tang H; Peng C; Chen J
Tumour Biol; 2016 Nov; 37(11):14463-14477. PubMed ID: 27644253
[TBL] [Abstract][Full Text] [Related]
2. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.
Zhao M; Ang L; Huang J; Wang J
Tumour Biol; 2017 Feb; 39(2):1010428317691682. PubMed ID: 28222665
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
[TBL] [Abstract][Full Text] [Related]
6. A summary for molecular regulations of miRNAs in breast cancer.
Yahya SM; Elsayed GH
Clin Biochem; 2015 Apr; 48(6):388-96. PubMed ID: 25541018
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
8. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
9. miR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.
Wu Z; Li X; Cai X; Huang C; Zheng M
Tumour Biol; 2016 Jun; 37(6):7939-50. PubMed ID: 26700673
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
12. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer.
Zhan Y; Li X; Liang X; Li L; Cao B; Wang B; Ma J; Ding F; Wang X; Pang D; Liu Z
Oncotarget; 2017 Jan; 8(3):4629-4641. PubMed ID: 27894095
[TBL] [Abstract][Full Text] [Related]
14. miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer.
Chu S; Liu G; Xia P; Chen G; Shi F; Yi T; Zhou H
Oncol Rep; 2017 Oct; 38(4):2401-2407. PubMed ID: 28765915
[TBL] [Abstract][Full Text] [Related]
15. miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells.
Harquail J; LeBlanc N; Ouellette RJ; Robichaud GA
Carcinogenesis; 2019 Aug; 40(8):1010-1020. PubMed ID: 30605519
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in colorectal cancer metastasis.
de Krijger I; Mekenkamp LJ; Punt CJ; Nagtegaal ID
J Pathol; 2011 Aug; 224(4):438-47. PubMed ID: 21706478
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy.
Peng F; Fan H; Li S; Peng C; Pan X
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299149
[TBL] [Abstract][Full Text] [Related]
18. Role of miR-155 in drug resistance of breast cancer.
Yu DD; Lv MM; Chen WX; Zhong SL; Zhang XH; Chen L; Ma TF; Tang JH; Zhao JH
Tumour Biol; 2015 Mar; 36(3):1395-401. PubMed ID: 25744731
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis.
Harquail J; Benzina S; Robichaud GA
Cancer Biomark; 2012; 11(6):269-80. PubMed ID: 23248185
[TBL] [Abstract][Full Text] [Related]
20. Regulation of microRNAs in cancer metastasis.
Bouyssou JM; Manier S; Huynh D; Issa S; Roccaro AM; Ghobrial IM
Biochim Biophys Acta; 2014 Apr; 1845(2):255-65. PubMed ID: 24569228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
